Skip to main content
Caplight Logo









Ribbon Bio

Ribbon Bio

Private
ViennaHealthcare & Life Scienceshttps://ribbonbio.com/

Last Round

Series A

Jan 31, 2022

Total Funding Raised

$21.86M

Company Overview

Ribbon Bio is a synthetic biology company that provides an automated, enzyme-based technology platform for the synthesis of long and complex DNA molecules.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

synthetic DNAlong DNA synthesisenzymatic DNA synthesisgene synthesissynthetic biologysynbiocomplex DNA synthesisDNA printingDNA manufacturingDNA as a Servicecustom DNA synthesisDNA synthesis servicegene therapyvaccine developmentfee-for-serviceantibody development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ribbon Bio Comparables

Compare Ribbon Bio with similar companies based on industry and business-model similarity.

Ribbon Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ansa Biotechnologies
87%
NunaBio Limited
84%
Synplogen Co., Ltd.
84%

Ribbon Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 31, 2022
Pre SeedMar 8, 2019

Ribbon Bio Investors

Notable investors and investment history

Ribbon Bio investors
InvestorRounds
tecnet equityPre Seed, Series A
Vienna Business AgencyGrant
Austria WirtschaftsserviceGrant, Pre Seed
xista science venturesPre Seed, Series A
European CommissionGrant
FFG Austrian Research Promotion AgencyGrant
Helicase VentureSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Monthly visitors increased 142% MoM.

  • Jan 22, 2025

    Grew 16% QoQ from 45 to 52 employees.

Ribbon Bio Filings

Explore SEC and related filing metadata, where available.

Ribbon Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ribbon Bio's valuation, stock price, and market status.

Is Ribbon Biolabs a public or private company?

Ribbon Biolabs is a private company.

What is the current stock price of Ribbon Biolabs?

Ribbon Biolabs is a private company with no public stock price. No recent secondary market data is available.

How much is Ribbon Biolabs worth (valuation)?

Valuation information for Ribbon Biolabs is not publicly available.

Can I buy Ribbon Biolabs stock?

Ribbon Biolabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ribbon Biolabs's last funding round?

Ribbon Biolabs's most recent funding round was Series A on January 31, 2022.

Who are the main investors in Ribbon Biolabs?

Key investors in Ribbon Biolabs include Hadean Ventures.

Will Ribbon Biolabs IPO soon?

No public IPO plans have been announced for Ribbon Biolabs.

How can I track Ribbon Biolabs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ribbon Biolabs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVienna
Employee Range47
Year Founded2018
Last FundingJan 31, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?